Yonkers, NY, United States of America

Mark D Cerutti

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.2

ph-index = 1


Location History:

  • Yonkers, NY (US) (2023)
  • Everett, MA (US) (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark D. Cerutti: Innovator in Continuous Glucose Monitoring Technology

Introduction

Mark D. Cerutti is a notable inventor based in Yonkers, NY, who has made significant contributions to the field of continuous glucose monitoring (CGM) technology. With a total of 4 patents to his name, Cerutti's work focuses on improving the accuracy and reliability of glucose measurements for individuals managing diabetes.

Latest Patents

Cerutti's latest patents include innovative methods for determining glucose values during CGM measurements. One of his key inventions is a method for non-steady-state determination of analyte concentration, which involves a CGM device equipped with a sensor, memory, and processor. This method applies a constant voltage potential to the sensor, measures a primary current signal, and utilizes a probing potential modulation sequence to enhance the accuracy of glucose concentration readings. Another significant patent focuses on continuous analyte monitoring sensor calibration, which also employs a connection function to refine glucose concentration determinations.

Career Highlights

Mark D. Cerutti is currently associated with Ascensia Diabetes Care Holdings AG, a company dedicated to developing innovative solutions for diabetes management. His work at Ascensia emphasizes the importance of precise glucose monitoring, which is crucial for effective diabetes care.

Collaborations

Cerutti collaborates with Huan-Ping Wu, contributing to advancements in CGM technology and enhancing the overall effectiveness of diabetes management tools.

Conclusion

Mark D. Cerutti's contributions to continuous glucose monitoring technology reflect his commitment to improving the lives of individuals with diabetes. His innovative patents and collaborative efforts continue to pave the way for advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…